Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Debt Ratio (2020 - 2022)

Historic Debt Ratio for Mereo BioPharma (MREO) over the last 3 years, with Q4 2022 value amounting to 0.01.

  • Mereo BioPharma's Debt Ratio fell 9448.24% to 0.01 in Q4 2022 from the same period last year, while for Dec 2022 it was 0.01, marking a year-over-year decrease of 9448.24%. This contributed to the annual value of 0.11 for FY2021, which is 5562.97% down from last year.
  • According to the latest figures from Q4 2022, Mereo BioPharma's Debt Ratio is 0.01, which was down 9448.24% from 0.15 recorded in Q2 2022.
  • Mereo BioPharma's Debt Ratio's 5-year high stood at 0.26 during Q4 2020, with a 5-year trough of 0.01 in Q4 2022.
  • Its 3-year average for Debt Ratio is 0.13, with a median of 0.13 in 2021.
  • Examining YoY changes over the last 5 years, Mereo BioPharma's Debt Ratio showed a top increase of 1931.99% in 2022 and a maximum decrease of 9448.24% in 2022.
  • Mereo BioPharma's Debt Ratio (Quarter) stood at 0.26 in 2020, then tumbled by 55.63% to 0.11 in 2021, then tumbled by 94.48% to 0.01 in 2022.
  • Its last three reported values are 0.01 in Q4 2022, 0.15 for Q2 2022, and 0.11 during Q4 2021.